Business Context and Reporting Period
Company: Future Vision II Acquisition Corp. (FVN)
Reporting Period: Quarter ended September 30, 2024 (Inception: January 30, 2024)
Status: The Company is a Cayman Islands exempted company and a "blank check" SPAC formed to effect a business combination. It has not commenced operations or selected a target. The Company consummated its Initial Public Offering (IPO) on September 13, 2024, selling 5,750,000 units (including over-allotment) at $10.00 per unit.
Key Financial Metrics
| Metric | Value (USD) |
|---|---|
| Total Assets | $59,409,351 |
| Cash and Cash Equivalents (Operating) | $1,464,303 |
| Marketable Securities (Trust Account) | $57,935,279 |
| Total Liabilities | $80,667 |
| Ordinary Shares Subject to Redemption | $52,654,348 (5,750,000 shares) |
| Shareholders' Equity | $6,674,336 |
| Net Income (3 months ended Sept 30, 2024) | $141,906 |
| Net Income (Inception to Sept 30, 2024) | $137,178 |
| Operating Expenses (3 months) | $6,585 |
| Operating Expenses (Inception to date) | $11,313 |
Material Changes and IPO Activity
The reporting period covers the Company's inception and the consummation of its IPO. Key financial movements include:
- Capital Raise: Gross proceeds of $57,500,000 from the IPO (5,000,000 units + 750,000 over-allotment units). Additionally, $2,990,000 was raised via a private placement to the Sponsor.
- Trust Account: $57,500,000 was deposited into the Trust Account. As of September 30, 2024, the Trust Account balance grew to $57,935,279 due to interest income of $147,779.
- Offering Costs: Total offering costs were $1,845,513, including $862,500 in cash underwriting fees, $522,019 in representative shares, and $460,994 in other costs.
- Deferred Compensation: A deferred underwriting commission of $575,000 (cash) and 28,750 shares is payable upon the consummation of a business combination.
Outlook, Risks, and Management Commentary
Going Concern: Management has determined that the mandatory liquidation requirement if a business combination is not completed within 18 months (or up to 24 months with extensions) raises substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include adjustments that might result from this uncertainty.
Liquidity: The Company has $1,464,303 in cash outside the Trust Account for working capital. Liquidity needs are expected to be met by these funds and potential working capital loans from the Sponsor or affiliates. No working capital loans were outstanding as of September 30, 2024.
Timeline: The Company has until March 13, 2026 (18 months from IPO) to complete a business combination, with the option to extend up to six additional months.
Management Changes: On October 14, 2024, Wang Xiaodong resigned as CEO and Director. Xu Danhua was appointed as the new CEO and Director effective October 18, 2024.
Risks: The Company has no revenue and relies entirely on interest income from the Trust Account. If a business combination is not completed, the Company will liquidate, and public shareholders will receive a pro-rata share of the Trust Account (approx. $10.05 per share plus interest), while warrants and rights will expire worthless.
Investor Verification Checklist
- Trust Account Balance: Verify the current balance of $57,935,279 and the per-share redemption value (approx. $10.05 + accrued interest).
- Extension Rights: Confirm the specific terms and costs associated with extending the 18-month combination period.
- Deferred Fees: Note the $575,000 deferred underwriting fee payable only upon a successful business combination.
- Management Transition: Review the background and experience of the newly appointed CEO, Xu Danhua.
- Going Concern Status: Acknowledge the substantial doubt regarding the Company's ability to continue as a going concern absent a business combination.